Findings About Dostarlimab, A New Antibody Drug, Very Encouraging, Says Expert In Cancer Treatment | Online Marketing Tools | Scoop.it
From onlinemarketingscoops.com - June 11, 2022 12:57 PM
According to New York Times, in a small clinical trial, 18 patients took a drug called Dostarlimab for around six months, and in the end, every one of them saw their tumours disappear. The findings…